Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aribert Rothenberger

Showing results (31-40 of 229) with videos related to

Pageof 23
Sort By:
Current Pharmaceutical Design|June 2, 2010
Postnatal brain development and psychotropic drugs. Effects on animals and animal models of depression and attention-deficit/hyperactivity disorderNathalie Bock, Manfred Gerlach, Aribert Rothenberger
Supplements to Clinical Neurophysiology|September 24, 2013
Event-related oscillations reflect functional asymmetry in children with attention deficit/hyperactivity disorderJuliana Yordanova, Vasil Kolev, Aribert Rothenberger
Journal of Attention Disorders|September 25, 2013
Daily Symptom Profiles of Children With ADHD Treated With Modified-Release MethylphenidateChristopher Hautmann, Aribert Rothenberger, Manfred Döpfner
MMW Fortschritte Der Medizin|January 29, 2010
[Therapy of chronic tic disorders]Veit Roessner, Tobias Banaschewski, Aribert Rothenberger
European Child & Adolescent Psychiatry|August 24, 2004
Areas for future investment in the field of ADHD: preschoolers and clinical networksManfred Döpfner, Aribert Rothenberger, Edmund Sonuga-Barke
European Child & Adolescent Psychiatry|November 16, 2010
Tourette's disorder and other tic disorders in DSM-5: a commentVeit Roessner, Pieter J Hoekstra, Aribert Rothenberger
European Child & Adolescent Psychiatry|April 10, 2013
Core features and associated psychopathology of Tourette syndrome: modifications by cultural aspects?Aribert Rothenberger, Andreas Becker, L Geza Rothenberger
Child and Adolescent Psychiatry and Mental Health|January 30, 2009
Change in the direct cost of treatment for children and adolescents with hyperkinetic disorder in Germany over a period of four yearsPeter M Wehmeier, Alexander Schacht, Aribert Rothenberger
Current Pharmaceutical Design|June 2, 2010
Psychotropic drugs in child and adolescent psychiatry--a new era at the horizonAribert Rothenberger, Manfred Gerlach, Ralf W Dittmann
The Behavioral and Brain Sciences|June 30, 2010
Comorbidity in the context of neural network propertiesJuliana Yordanova, Vasil Kolev, Roumen Kirov, et al.
Pageof 23

Showing results (31-40 of 229) with videos related to

Sort By:
Pageof 23
Current Pharmaceutical Design|June 2, 2010
Postnatal brain development and psychotropic drugs. Effects on animals and animal models of depression and attention-deficit/hyperactivity disorderNathalie Bock, Manfred Gerlach, Aribert Rothenberger
Supplements to Clinical Neurophysiology|September 24, 2013
Event-related oscillations reflect functional asymmetry in children with attention deficit/hyperactivity disorderJuliana Yordanova, Vasil Kolev, Aribert Rothenberger
Journal of Attention Disorders|September 25, 2013
Daily Symptom Profiles of Children With ADHD Treated With Modified-Release MethylphenidateChristopher Hautmann, Aribert Rothenberger, Manfred Döpfner
MMW Fortschritte Der Medizin|January 29, 2010
[Therapy of chronic tic disorders]Veit Roessner, Tobias Banaschewski, Aribert Rothenberger
European Child & Adolescent Psychiatry|August 24, 2004
Areas for future investment in the field of ADHD: preschoolers and clinical networksManfred Döpfner, Aribert Rothenberger, Edmund Sonuga-Barke
European Child & Adolescent Psychiatry|November 16, 2010
Tourette's disorder and other tic disorders in DSM-5: a commentVeit Roessner, Pieter J Hoekstra, Aribert Rothenberger
European Child & Adolescent Psychiatry|April 10, 2013
Core features and associated psychopathology of Tourette syndrome: modifications by cultural aspects?Aribert Rothenberger, Andreas Becker, L Geza Rothenberger
Child and Adolescent Psychiatry and Mental Health|January 30, 2009
Change in the direct cost of treatment for children and adolescents with hyperkinetic disorder in Germany over a period of four yearsPeter M Wehmeier, Alexander Schacht, Aribert Rothenberger
Current Pharmaceutical Design|June 2, 2010
Psychotropic drugs in child and adolescent psychiatry--a new era at the horizonAribert Rothenberger, Manfred Gerlach, Ralf W Dittmann
The Behavioral and Brain Sciences|June 30, 2010
Comorbidity in the context of neural network propertiesJuliana Yordanova, Vasil Kolev, Roumen Kirov, et al.
Pageof 23